BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28418819)

  • 1. Cancer Genomics and Important Oncologic Mutations: A Contemporary Guide for Body Imagers.
    Cox VL; Bhosale P; Varadhachary GR; Wagner-Bartak N; Glitza IC; Gold KA; Atkins JT; Soliman PT; Hong DS; Qayyum A
    Radiology; 2017 May; 283(2):314-340. PubMed ID: 28418819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decoding Genes: Current Update on Radiogenomics of Select Abdominal Malignancies.
    Katabathina VS; Marji H; Khanna L; Ramani N; Yedururi S; Dasyam A; Menias CO; Prasad SR
    Radiographics; 2020 Oct; 40(6):1600-1626. PubMed ID: 33001791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterizing genomic alterations in cancer by complementary functional associations.
    Kim JW; Botvinnik OB; Abudayyeh O; Birger C; Rosenbluh J; Shrestha Y; Abazeed ME; Hammerman PS; DiCara D; Konieczkowski DJ; Johannessen CM; Liberzon A; Alizad-Rahvar AR; Alexe G; Aguirre A; Ghandi M; Greulich H; Vazquez F; Weir BA; Van Allen EM; Tsherniak A; Shao DD; Zack TI; Noble M; Getz G; Beroukhim R; Garraway LA; Ardakani M; Romualdi C; Sales G; Barbie DA; Boehm JS; Hahn WC; Mesirov JP; Tamayo P
    Nat Biotechnol; 2016 May; 34(5):539-46. PubMed ID: 27088724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide mutational spectra analysis reveals significant cancer-specific heterogeneity.
    Tan H; Bao J; Zhou X
    Sci Rep; 2015 Jul; 5():12566. PubMed ID: 26212640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From K-space to Nucleotide: Insights Into the Radiogenomics of Brain Tumors.
    Elshafeey N; Hassan I; Zinn PO; Colen RR
    Top Magn Reson Imaging; 2017 Feb; 26(1):33-41. PubMed ID: 28079715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Pan-Cancer Catalogue of Cancer Driver Protein Interaction Interfaces.
    Porta-Pardo E; Garcia-Alonso L; Hrabe T; Dopazo J; Godzik A
    PLoS Comput Biol; 2015 Oct; 11(10):e1004518. PubMed ID: 26485003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Background, current role, and potential applications of radiogenomics.
    Pinker K; Shitano F; Sala E; Do RK; Young RJ; Wibmer AG; Hricak H; Sutton EJ; Morris EA
    J Magn Reson Imaging; 2018 Mar; 47(3):604-620. PubMed ID: 29095543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Status of Cancer Genomics and Imaging Phenotypes: What Radiologists Need to Know.
    Mendes Serrão E; Klug M; Moloney BM; Jhaveri A; Lo Gullo R; Pinker K; Luker G; Haider MA; Shinagare AB; Liu X
    Radiol Imaging Cancer; 2023 Nov; 5(6):e220153. PubMed ID: 37921555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic mutations associated with MRI-derived volumetric features in glioblastoma.
    Gutman DA; Dunn WD; Grossmann P; Cooper LA; Holder CA; Ligon KL; Alexander BM; Aerts HJ
    Neuroradiology; 2015 Dec; 57(12):1227-37. PubMed ID: 26337765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast MRI radiogenomics: Current status and research implications.
    Grimm LJ
    J Magn Reson Imaging; 2016 Jun; 43(6):1269-78. PubMed ID: 26663695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiogenomics: what it is and why it is important.
    Mazurowski MA
    J Am Coll Radiol; 2015 Aug; 12(8):862-6. PubMed ID: 26250979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Gene Expression Pattern Related to Breast Cancer Survival Using Integrated TCGA Datasets and Genomic Tools.
    Huang Z; Duan H; Li H
    Biomed Res Int; 2015; 2015():878546. PubMed ID: 26576432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiogenomics and IR.
    Lam A; Bui K; Hernandez Rangel E; Nguyentat M; Fernando D; Nelson K; Abi-Jaoudeh N
    J Vasc Interv Radiol; 2018 May; 29(5):706-713. PubMed ID: 29551544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of somatic mutation in human cancer genomes.
    Greenman C; Stephens P; Smith R; Dalgliesh GL; Hunter C; Bignell G; Davies H; Teague J; Butler A; Stevens C; Edkins S; O'Meara S; Vastrik I; Schmidt EE; Avis T; Barthorpe S; Bhamra G; Buck G; Choudhury B; Clements J; Cole J; Dicks E; Forbes S; Gray K; Halliday K; Harrison R; Hills K; Hinton J; Jenkinson A; Jones D; Menzies A; Mironenko T; Perry J; Raine K; Richardson D; Shepherd R; Small A; Tofts C; Varian J; Webb T; West S; Widaa S; Yates A; Cahill DP; Louis DN; Goldstraw P; Nicholson AG; Brasseur F; Looijenga L; Weber BL; Chiew YE; DeFazio A; Greaves MF; Green AR; Campbell P; Birney E; Easton DF; Chenevix-Trench G; Tan MH; Khoo SK; Teh BT; Yuen ST; Leung SY; Wooster R; Futreal PA; Stratton MR
    Nature; 2007 Mar; 446(7132):153-8. PubMed ID: 17344846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging and the completion of the omics paradigm in breast cancer.
    Leithner D; Horvat JV; Ochoa-Albiztegui RE; Thakur S; Wengert G; Morris EA; Helbich TH; Pinker K
    Radiologe; 2018 Nov; 58(Suppl 1):7-13. PubMed ID: 29947931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of radiomics in predicting gene mutations in cancer.
    Qi Y; Zhao T; Han M
    Eur Radiol; 2022 Jun; 32(6):4014-4024. PubMed ID: 35048135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational design of cancer gene panels with OncoPaD.
    Rubio-Perez C; Deu-Pons J; Tamborero D; Lopez-Bigas N; Gonzalez-Perez A
    Genome Med; 2016 Oct; 8(1):98. PubMed ID: 27716338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multigene Panel Testing Detects Equal Rates of Pathogenic BRCA1/2 Mutations and has a Higher Diagnostic Yield Compared to Limited BRCA1/2 Analysis Alone in Patients at Risk for Hereditary Breast Cancer.
    Kapoor NS; Curcio LD; Blakemore CA; Bremner AK; McFarland RE; West JG; Banks KC
    Ann Surg Oncol; 2015 Oct; 22(10):3282-8. PubMed ID: 26219241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and analysis of driver missense mutations using rotation forest with feature selection.
    Du X; Cheng J
    Biomed Res Int; 2014; 2014():905951. PubMed ID: 25250338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.